Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+15.4%
5Y CAGR+18.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+15.4%/yr
Annual compound
5Y CAGR
+18.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $97.03M | +8.6% |
| 2024 | $89.35M | +6.9% |
| 2023 | $83.59M | +32.6% |
| 2022 | $63.06M | +29.2% |
| 2021 | $48.81M | +18.7% |
| 2020 | $41.13M | +40.8% |
| 2019 | $29.21M | - |